Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.96 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.96 |
| ▸ | MAPT | P10636 | 5/20 | 0.96 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.96 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.96 |
| ▸ | HTT | P42858 | 3/20 | 0.96 |
| ▸ | GFER | P55789 | 2/20 | 0.96 |
| ▸ | LMNA | P02545 | 2/20 | 0.96 |
| ▸ | THRB | P10828 | 2/20 | 0.96 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.96 |
| ▸ | ALPG | P10696 | 1/20 | 0.96 |
| ▸ | CASP1 | P29466 | 2/20 | 0.69 |
| ▸ | HBB | P68871 | 2/20 | 0.69 |
| ▸ | GAA | P10253 | 2/20 | 0.69 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.69 |
| ▸ | CASP7 | P55210 | 1/20 | 0.69 |
| ▸ | RELA | Q04206 | 1/20 | 0.61 |
| ▸ | APP | P05067 | 4/20 | 0.59 |
| ▸ | RAB9A | P51151 | 6/20 | 0.57 |
| ▸ | NPC1 | O15118 | 5/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1898081 | 1.00 | MEN1 (0.96) | MEN1KMT2AMAPTSMN1; SMN2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28626066 | 0.98 | MEN1 (0.92) | MEN1KMT2AMAPTSMN1; SMN2ALDH1A1 | |
| Iodide SCHEMBL531167 | 0.98 | MEN1 (1.00) | MEN1KMT2AMAPTSMN1; SMN2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28626064 | 0.98 | MEN1 (0.92) | MEN1KMT2AMAPTSMN1; SMN2ALDH1A1 | |
| Iodide SCHEMBL531166 | 0.98 | MEN1 (1.00) | MEN1KMT2AMAPTSMN1; SMN2ALDH1A1 | |
| Iodide SCHEMBL31193459 | 0.90 | MEN1 (0.86) | MEN1KMT2AMAPTSMN1; SMN2ALDH1A1 | |
| Iodide SCHEMBL31553417 | 0.90 | MEN1 (0.86) | MEN1KMT2AMAPTSMN1; SMN2ALDH1A1 | |
| Perchlorate SCHEMBL29959624 | 0.86 | MAPT (0.72) | MEN1KMT2AMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL7034006 | 0.85 | MEN1 (0.71) | MEN1KMT2AMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL15624211 | 0.85 | ALDH1A1 (0.71) | MEN1KMT2AMAPTSMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12596125-B2 | Nano-rheological biomarkers for early and improved follow-up of pathologies associated to RBC deformability alteration | ALCEDIAG (FR) | 2026-04-07 | — | — | US | claimed |
| US-20220299533-A1 | NANO-RHEOLOGICAL BIOMARKERS FOR EARLY AND IMPROVED FOLLOW-UP OF PATHOLOGIES ASSOCIATED TO RBC DEFORMABILITY ALTERATION | UNIVERSITÉ PARIS CITÉ (FR) | 2022-09-22 | — | — | US | claimed |
| EP-3983802-A1 | NANO-RHEOLOGICAL BIOMARKERS FOR EARLY AND IMPROVED FOLLOW-UP OF PATHOLOGIES ASSOCIATED TO RBC DEFORMABILITY ALTERATION | ALCEDIAG (FR) | 2022-04-20 | — | — | EP | claimed |
| EP-2516995-B1 | SERS-BASED ANALYTE DETECTION | AGENCY SCIENCE TECH & RES (SG) | 2016-10-26 | — | — | EP | claimed |
| WO-2010144438-A1 | PHOTOVOLTAIC DEVICE WITH FREQUENCY CONVERSION REGION | WAKE FOREST UNIVERSITY (US) | 2010-12-16 | — | — | WO | claimed |
| EP-1200051-B1 | AGENT FOR DYING KERATIN FIBERS | HENKEL KGAA (DE) | 2006-02-01 | — | — | EP | claimed |
| US-20050048000-A1 | Amyloid targeting imaging agents and uses thereof | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2005-03-03 | — | — | US | claimed |
| EP-1121567-B1 | LUMINESCENT BRITTLE COATING IN STRAIN ANALYSIS | UNIV FLORIDA (US) | 2004-09-15 | — | — | EP | claimed |
| EP-1303311-A2 | AMYLOID TARGETING IMAGING AGENTS AND USES THEREOF | Neurochem, Inc. (CA) | 2003-04-23 | — | — | EP | claimed |
| US-20020115717-A1 | Amyloid targeting imaging agents and uses thereof | NEUROCHEM (INTERNATIONAL) LIMITED (GI) | 2002-08-22 | — | — | US | claimed |
| WO-2002007781-A2 | AMYLOID TARGETING IMAGING AGENTS AND USES THEREOF | NEUROCHEM INC. (CA) | 2002-01-31 | — | — | WO | claimed |
| US-12596125-B2 | Nano-rheological biomarkers for early and improved follow-up of pathologies associated to RBC deformability alteration | ALCEDIAG (FR) | 2026-04-07 | — | — | US | disclosed |
| WO-2024058527-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEARING LOSS COMPRISING ESOMEPRAZOLE OR DEXLANSOPRAZOLE AS ACTIVE INGREDIENT | 고려대학교 산학협력단 | 2024-03-21 | — | — | WO | disclosed |
| US-20230240954-A1 | USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION | L'OREAL (FR) | 2023-08-03 | — | — | US | disclosed |
| US-20220299533-A1 | NANO-RHEOLOGICAL BIOMARKERS FOR EARLY AND IMPROVED FOLLOW-UP OF PATHOLOGIES ASSOCIATED TO RBC DEFORMABILITY ALTERATION | UNIVERSITÉ PARIS CITÉ (FR) | 2022-09-22 | — | — | US | disclosed |
| EP-1303311-A2 | AMYLOID TARGETING IMAGING AGENTS AND USES THEREOF | Neurochem, Inc. (CA) | 2003-04-23 | — | — | EP | disclosed |
| US-20020115717-A1 | Amyloid targeting imaging agents and uses thereof | NEUROCHEM (INTERNATIONAL) LIMITED (GI) | 2002-08-22 | — | — | US | disclosed |
| US-6402037-B1 | Two-photon upconverting dyes and applications | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK | 2002-06-11 | — | — | US | disclosed |
| WO-2002007781-A2 | AMYLOID TARGETING IMAGING AGENTS AND USES THEREOF | NEUROCHEM INC. (CA) | 2002-01-31 | — | — | WO | disclosed |
| US-5912257-A | COMPRISING A MATRIX AND STYRYL DYES AND CPOPOSITIONS SHOWING SUPERIOR TWO PHOTON ABSORPTION CROSS-SECTIONS; LASER COMPRISING SOUCE CAPABLE OF PRODUCING INFRARED RADIATION; MULTIPHASE MULTISTRUCTURAL COMPOSITES | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1999-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12596125-B2 | Nano-rheological biomarkers for early and improved follow-up of pathologies associated to RBC deformability alteration | SPTBN1, MB, HBZ | MEN1 430/4885KMT2A 2529/4885MAPT 2110/4885 |
| US-20050048000-A1 | Amyloid targeting imaging agents and uses thereof | APP, APBA1, BACE1 | MEN1 605/4885KMT2A 3512/4885MAPT 10/4885 |
| US-20230240954-A1 | USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION | KRT18, CUTA, KLK5 | MEN1 2794/4885KMT2A 2181/4885MAPT 1599/4885 |
| US-20020115717-A1 | Amyloid targeting imaging agents and uses thereof | APP, APBA1, BACE1 | MEN1 605/4885KMT2A 3512/4885MAPT 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.